Bureaucratic representation and gender mainstreaming in international organizations: evidence from the World Bank

How does the representation of women in international organizations affect the implementation of gender mainstreaming policies? Many international organizations have adopted policies to prevent gender discrimination in their operations, but their implementation is often lackluster. We argue that these shortcomings appear due to a combination of institutional incentives and an underrepresentation of women in their staff. We test the argument in the case of the World Bank, drawing on highly disaggregated staffing data, an instrumental variable strategy, and an elite survey experiment. Our results show that most staff incorporate at least shallow gender mainstreaming in their projects. Deeper implementation of gender mainstreaming is more likely when women staff supervise projects, hold positions of authority, and are more represented as coworkers. These results contribute to understanding the disconnects between talk and action on mainstreaming policies and inform debates on representation in global governance

A Novel Codon-optimized SIV Gag-pol Immunogen for Genebased Vaccination

Simian immunodeficiency virus (SIV) is a robust pathogen used in non-human primates to model HIV vaccines. SIV encodes a number of potential vaccine targets. By far the largest and most conserved protein target in SIV is its gag-pol protein that bears many epitopes to drive multivalent immune T cell responses. While gag-pol is an attractive antigen, it is only translated after a frame shift between gag and pol with the effect that gag and pol are expressed at an approximate 10/1 ratio. The codon bias of native lentiviral genes are also mismatched with the abundance of tRNAs in mammalian cells resulting in poor expression of unmodified SIV genes. To provide a better SIV gag-pol immunogen for gene-based vaccination, we codon-optimized the full gag-pol sequence from SIVmac239. To increase pol expression, we artificially moved the pol sequence in frame to gag to bypass the need for a translational frame shift for its expression. Finally, we inserted four self-cleaving picornavirus sequences into gag p24, protease, reverse transcriptase, and into integrase to fragment the proteins for potentially better immune presentation. We demonstrate that these immunogens are well expressed in vitro and drive similar antibody and T cell responses with or without cleavage sequences

A Novel Codon-optimized SIV Gag-pol Immunogen for Genebased Vaccination

Simian immunodeficiency virus (SIV) is a robust pathogen used in non-human primates to model HIV vaccines. SIV encodes a number of potential vaccine targets. By far the largest and most conserved protein target in SIV is its gag-pol protein that bears many epitopes to drive multivalent immune T cell responses. While gag-pol is an attractive antigen, it is only translated after a frame shift between gag and pol with the effect that gag and pol are expressed at an approximate 10/1 ratio. The codon bias of native lentiviral genes are also mismatched with the abundance of tRNAs in mammalian cells resulting in poor expression of unmodified SIV genes. To provide a better SIV gag-pol immunogen for gene-based vaccination, we codon-optimized the full gag-pol sequence from SIVmac239. To increase pol expression, we artificially moved the pol sequence in frame to gag to bypass the need for a translational frame shift for its expression. Finally, we inserted four self-cleaving picornavirus sequences into gag p24, protease, reverse transcriptase, and into integrase to fragment the proteins for potentially better immune presentation. We demonstrate that these immunogens are well expressed in vitro and drive similar antibody and T cell responses with or without cleavage sequences

A Novel Codon-optimized SIV Gag-pol Immunogen for Genebased Vaccination

Simian immunodeficiency virus (SIV) is a robust pathogen used in non-human primates to model HIV vaccines. SIV encodes a number of potential vaccine targets. By far the largest and most conserved protein target in SIV is its gag-pol protein that bears many epitopes to drive multivalent immune T cell responses. While gag-pol is an attractive antigen, it is only translated after a frame shift between gag and pol with the effect that gag and pol are expressed at an approximate 10/1 ratio. The codon bias of native lentiviral genes are also mismatched with the abundance of tRNAs in mammalian cells resulting in poor expression of unmodified SIV genes. To provide a better SIV gag-pol immunogen for gene-based vaccination, we codon-optimized the full gag-pol sequence from SIVmac239. To increase pol expression, we artificially moved the pol sequence in frame to gag to bypass the need for a translational frame shift for its expression. Finally, we inserted four self-cleaving picornavirus sequences into gag p24, protease, reverse transcriptase, and into integrase to fragment the proteins for potentially better immune presentation. We demonstrate that these immunogens are well expressed in vitro and drive similar antibody and T cell responses with or without cleavage sequences

Outracing Human Racers with Model-based Planning and Control for Time-trial Racing

Autonomous racing has become a popular sub-topic of autonomous driving in recent years. The goal of autonomous racing research is to develop software to control the vehicle at its limit of handling and achieve human-level racing performance. In this work, we investigate how to approach human expert-level racing performance with model-based planning and control methods using the high-fidelity racing simulator Gran Turismo Sport (GTS). GTS enables a unique opportunity for autonomous racing research, as many recordings of racing from highly skilled human players can served as expert emonstrations. By comparing the performance of the autonomous racing software with human experts, we better understand the performance gap of existing software and explore new methodologies in a principled manner. In particular, we focus on the commonly adopted model-based racing framework, consisting of an offline trajectory planner and an online Model Predictive Control-based (MPC) tracking controller. We thoroughly investigate the design challenges from three perspective, namely vehicle model, planning algorithm, and controller design, and propose novel solutions to improve the baseline approach toward human expert-level performance. We showed that the proposed control framework can achieve top 0.95% lap time among human-expert players in GTS. Furthermore, we conducted comprehensive ablation studies to validate the necessity of proposed modules, and pointed out potential future directions to reach human-best performance.Comment: 16 pages, 13 figures, 3 table

Leap Forward: Advancing LEAP's Land Use Goals

http://deepblue.lib.umich.edu/bitstream/2027.42/110959/1/leap_forwardreduced.pd

Contemporary Family Law, 6th Edition

Jessica Dixon Weaver: https://orcid.org/0000-0002-6960-1459https://scholar.smu.edu/facbooks/1071/thumbnail.jp

Photometry of Kuiper belt object (486958) Arrokoth from New Horizons LORRI

On January 1st 2019, the New Horizons spacecraft flew by the classical Kuiper belt object (486958) Arrokoth (provisionally designated 2014 MU69), possibly the most primitive object ever explored by a spacecraft. The I/F of Arrokoth is analyzed and fit with a photometric function that is a linear combination of the Lommel-Seeliger (lunar) and Lambert photometric functions. Arrokoth has a geometric albedo of p_v = 0.21_(−0.04)^(+0.05) at a wavelength of 550 nm and ≈0.24 at 610 nm. Arrokoth's geometric albedo is greater than the median but consistent with a distribution of cold classical Kuiper belt objects whose geometric albedos were determined by fitting a thermal model to radiometric observations. Thus, Arrokoth's geometric albedo adds to the orbital and spectral evidence that it is a cold classical Kuiper belt object. Maps of the normal reflectance and hemispherical albedo of Arrokoth are presented. The normal reflectance of Arrokoth's surface varies with location, ranging from ≈0.10–0.40 at 610 nm with an approximately Gaussian distribution. Both Arrokoth's extrema dark and extrema bright surfaces are correlated to topographic depressions. Arrokoth has a bilobate shape and the two lobes have similar normal reflectance distributions: both are approximately Gaussian, peak at ≈0.25 at 610 nm, and range from ≈0.10–0.40, which is consistent with co-formation and co-evolution of the two lobes. The hemispherical albedo of Arrokoth varies substantially with both incidence angle and location, the average hemispherical albedo at 610 nm is 0.063 ± 0.015. The Bond albedo of Arrokoth at 610 nm is 0.062 ± 0.015

Bone Marrow–on–a–Chip Replicates Hematopoietic Niche Physiology in Vitro

Current in vitro hematopoiesis models fail to demonstrate the cellular diversity and complex functions of living bone marrow; hence, most translational studies relevant to the hematologic system are conducted in live animals. Here we describe a method for fabricating 'bone marrow–on–a–chip' that permits culture of living marrow with a functional hematopoietic niche in vitro by first engineering new bone in vivo, removing it whole and perfusing it with culture medium in a microfluidic device. The engineered bone marrow (eBM) retains hematopoietic stem and progenitor cells in normal in vivo–like proportions for at least 1 week in culture. eBM models organ-level marrow toxicity responses and protective effects of radiation countermeasure drugs, whereas conventional bone marrow culture methods do not. This biomimetic microdevice offers a new approach for analysis of drug responses and toxicities in bone marrow as well as for study of hematopoiesis and hematologic diseases in vitro.Engineering and Applied Science